We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$4.05B
AUM Growth
+$375M
Cap. Flow
+$164M
Cap. Flow %
4.05%
Top 10 Hldgs %
45.11%
Holding
463
New
50
Increased
205
Reduced
169
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.3%
2 Technology 14.03%
3 Healthcare 5.35%
4 Financials 4.48%
5 Communication Services 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
376
Diageo
DEO
$51.2B
$301K 0.01%
3,153
-280
-8% -$29.4K
IGSB icon
377
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$298K 0.01%
5,613
-848
-13% -$44.8K
APP icon
378
Applovin
APP
$105B
$292K 0.01%
+406
New +$187K
FIDU icon
379
Fidelity MSCI Industrials Index ETF
FIDU
$2.3B
$290K 0.01%
3,537
-541
-13% -$43.4K
SPGI icon
380
S&P Global
SPGI
$128B
$290K 0.01%
595
+4
+0.7% +$2.14K
VRIG icon
381
Invesco Variable Rate Investment Grade ETF
VRIG
$1.89B
$288K 0.01%
11,483
+144
+1% +$3.62K
INSM icon
382
Insmed
INSM
$26.5B
$288K 0.01%
+2,000
New +$245K
XLG icon
383
Invesco S&P 500 Top 50 ETF
XLG
$11B
$288K 0.01%
4,999
+7
+0.1% +$383
CNI icon
384
Canadian National Railway
CNI
$76.5B
$283K 0.01%
3,002
+20
+0.7% +$1.93K
MNST icon
385
Monster Beverage
MNST
$91.5B
$280K 0.01%
+8,320
New +$260K
BDX icon
386
Becton Dickinson
BDX
$51.2B
$280K 0.01%
1,495
+23
+2% +$4.27K
XBI icon
387
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$279K 0.01%
2,785
+1
+0% +$90
SAN icon
388
Banco Santander
SAN
$211B
$278K 0.01%
+26,513
New +$247K
CSWC icon
389
Capital Southwest
CSWC
$1.62B
$276K 0.01%
12,633
-670
-5% -$15.3K
TSLX icon
390
Sixth Street Specialty
TSLX
$1.79B
$273K 0.01%
11,924
-237
-2% -$5.7K
EBC icon
391
Eastern Bankshares
EBC
$5.12B
$270K 0.01%
14,901
+55
+0.4% +$907
O icon
392
Realty Income
O
$58.5B
$268K 0.01%
4,407
+111
+3% +$6.47K
BBUS icon
393
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.22B
$266K 0.01%
2,207
+7
+0.3% +$813
ALLE icon
394
Allegion
ALLE
$13.6B
$264K 0.01%
1,489
+30
+2% +$4.95K
HYD icon
395
VanEck High Yield Muni ETF
HYD
$4.34B
$263K 0.01%
5,161
-756
-13% -$37.6K
VEU icon
396
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$262K 0.01%
3,672
-20
-0.5% -$1.38K
FDX icon
397
FedEx
FDX
$78.4B
$259K 0.01%
1,099
+7
+0.6% +$1.61K
SPIB icon
398
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.7B
$259K 0.01%
+7,635
New +$257K
PWV icon
399
Invesco Large Cap Value ETF
PWV
$1.85B
$252K 0.01%
3,871
CACI icon
400
CACI
CACI
$14B
$249K 0.01%
500

Similar funds

Grimes & Company's Q3 2025 Portfolio in Review

As of Q3 2025, Grimes & Company held 463 positions worth $4.05B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $164M of net new capital in Q3 2025, opening 50 new positions and adding to 205 existing holdings. Its largest new stake was State Street Materials Select Sector SPDR ETF: 457,276 shares worth $20.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Short-Term National Muni Bond ETF, an estimated $57.9M trimmed.

  • Grimes & Company's largest Q3 2025 buy was State Street Materials Select Sector SPDR ETF: 457,276 shares worth $20.5M.
  • Grimes & Company added most to Vanguard Morningstar Small-Cap ETF in Q3 2025, an estimated $123M increase.
  • Grimes & Company's biggest Q3 2025 reduction was iShares Short-Term National Muni Bond ETF, cutting an estimated $57.9M.
  • Grimes & Company fully exited Avantis US Small Cap Value ETF in Q3 2025, selling an estimated $443K.
  • Grimes & Company's ten largest holdings make up 45% of its $4.05B portfolio in Q3 2025.
  • Grimes & Company opened 50 new positions and closed 13 in Q3 2025.
  • Grimes & Company's portfolio value rose 10% quarter-over-quarter to $4.05B.

Based on Grimes & Company's 13F filing for Q3 2025, filed 27 Oct 2025.